IA
CGEM icon

IFP Advisors’s Cullinan Oncology CGEM Stock Holding History

IFP Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Buy
728
+415
+133% +$6.16K ﹤0.01% 3220
2026
Q1 		$4.45K Hold
313
– – ﹤0.01% 3594
2025
Q4 		$3.24K Buy
313
+166
+113% +$1.5K ﹤0.01% 3639
2025
Q3 		$872 Buy
+147
New +$1.08K ﹤0.01% 4007
2025
Q2 		– Hold
0
– – – 4320
2025
Q1 		– Hold
0
– – – 3955
2024
Q4 		– Hold
0
– – – 3998

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

IFP Advisors's CGEM Position: Q2 2026 in Review

IFP Advisors increased its Cullinan Oncology (CGEM) stake by 133% in Q2 2026, buying an estimated $6.16K and bringing the position to 728 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3220.

IFP Advisors first reported a position in CGEM in Q3 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • IFP Advisors held 728 shares of Cullinan Oncology worth $13.3K as of Q2 2026.
  • IFP Advisors bought 415 Cullinan Oncology shares in Q2 2026, an estimated $6.16K.
  • Cullinan Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3220 holding.
  • IFP Advisors first reported a position in Cullinan Oncology in Q3 2025 and has held it in 4 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.